Glassman Wealth Services Alnylam Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $1,514 - $1,965	10 Added 7.35%	146 $27,000
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $853 - $1,058	-5 Reduced 3.55%	136 $24,000
Q2 2023 Aug 08, 2023	BUY	$185.01 - $212.05 $1,295 - $1,484	7 Added 5.22%	141 $26,000
Q1 2023 May 04, 2023	SELL	$182.66 - $235.53 $730 - $942	-4 Reduced 2.9%	134 $26,000
Q4 2022 Feb 06, 2023	BUY	$185.53 - $241.31 $742 - $965	4 Added 2.99%	138 $32,000
Q3 2022 Nov 09, 2022	BUY	$138.54 - $232.0 $277 - $464	2 Added 1.52%	134 $27,000
Q2 2022 Aug 04, 2022	SELL	$120.42 - $169.29 $5,418 - $7,618	-45 Reduced 25.42%	132 $19,000
Q1 2022 Aug 23, 2022	SELL	$127.18 - $173.91 $254 - $347	-2 Reduced 1.12%	177 $29,000
Q1 2022 Apr 14, 2022	BUY	$127.18 - $173.91 $3,688 - $5,043	29 Added 19.33%	179 $29,000
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $2,074 - $2,720	13 Added 9.49%	150 $25,000
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $339 - $415	2 Added 1.48%	137 $26,000
Q2 2021 Aug 04, 2021	BUY	$128.63 - $176.89 $257 - $353	2 Added 1.5%	135 $23,000
Q1 2021 May 05, 2021	SELL	$126.83 - $175.69 $253 - $351	-2 Reduced 1.48%	133 $19,000
Q4 2020 Feb 04, 2021	BUY	$122.97 - $147.0 $8,484 - $10,143	69 Added 104.55%	135 $18,000
Q3 2020 Nov 09, 2020	BUY	$121.19 - $165.49 $1,575 - $2,151	13 Added 24.53%	66 $10,000
Q2 2020 Aug 06, 2020	BUY	$104.21 - $156.44 $2,917 - $4,380	28 Added 112.0%	53 $8,000
Q1 2020 May 12, 2020	BUY	$93.12 - $133.99 $279 - $401	3 Added 13.64%	25 $3,000
Q3 2019 Nov 01, 2019	BUY	$70.9 - $87.82 $1,276 - $1,580	18 Added 450.0%	22 $2,000
Q2 2019 Aug 08, 2019	SELL	$65.86 - $92.79 $592 - $835	-9 Reduced 69.23%	4 $0
Q1 2019 May 10, 2019	BUY	$72.76 - $93.45 $945 - $1,214	13 New	13 $1,000
Q2 2018 Aug 09, 2018	SELL	$88.31 - $107.8 $264 - $323	-3 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$114.49 - $139.98 $343 - $419	3	3 $0

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.87 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$2.96 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.24 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.23 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.16 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account